Hypogammaglobulinemia due to CAR T-cell therapy

Pediatr Blood Cancer. 2018 Apr;65(4):10.1002/pbc.26914. doi: 10.1002/pbc.26914. Epub 2017 Dec 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinemia / etiology*
  • Agammaglobulinemia / pathology*
  • Female
  • Humans
  • Immunotherapy, Adoptive / adverse effects*
  • Male
  • Time Factors